thiophenes has been researched along with Mast-Cell Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castaldo, L; Garton, A; Haack, H; Haley, JD; Hunt, T; Kahler, J; McCormack, S; Nuwaysir, L; Petti, F; Sullivan, L; Thelemann, A; Zeiske, L | 1 |
| Arnold, LD; Bittner, MA; Briner, P; Brown, EN; Castaldo, L; Castelhano, AL; Chan, A; Cooke, AR; Crew, AP; Emerson, DL; Franklin, M; Franks, A; Garton, AJ; Gibson, NW; Hart, K; Henninger, D; Hidden, C; Kahler, J; Keily, JF; Li, AH; O'Connor, M; Pirrit, C; Richardson, F; Sennello, R; Srebernak, MC; Vulevic, B; Winski, SL; Wynne, GM; Zhang, T | 1 |
2 other study(ies) available for thiophenes and Mast-Cell Leukemia
| Article | Year |
|---|---|
Temporal quantitation of mutant Kit tyrosine kinase signaling attenuated by a novel thiophene kinase inhibitor OSI-930.
Topics: Antineoplastic Agents; Humans; Leukemia, Mast-Cell; Mutation; Neoplasm Proteins; Peptides; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Quinolines; Signal Transduction; Thiophenes; Tissue Array Analysis; Tumor Cells, Cultured | 2005 |
OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models.
Topics: Administration, Oral; Animals; Female; Humans; Leukemia, Mast-Cell; Mice; Mice, Nude; Proto-Oncogene Proteins c-kit; Quinolines; Thiophenes; Transplantation, Heterologous; Vascular Endothelial Growth Factor Receptor-2 | 2006 |